SYNGENE.NS Stock Quote & Alerts

SYNGENE.NSSYNGENE.NS

No data available

Want to monitor SYNGENE.NS?

Get notified when price crosses targets, volume spikes, or RSI hits oversold

No company information available

Explore More

Filter and sort all 500 stocks

Today's biggest gainers and losers

Visual sector performance

Alerts

Key Statistics

About

News

Why investors shouldn't panic yet about Trump's credit-card rate-cap proposal

Exagen Inc. Announces Select Preliminary 2025 Financial Results

REGENXBIO Highlights Key 2026 Catalysts and Announces Positive Long-Term Functional Outcomes in Lead Duchenne Gene Therapy Program

DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Gauzy

Cogent Insider Sells $2.5 Million in Stock Amid Staggering 300% Price Surge

This CoreWeave Rival Could Double in 2026

3 Popular Stocks That Could Wipe Out a $100,000 Nest Egg

Which Vanguard Dividend ETF is a Better Buy: VYM or VIG?

Pagaya Insider Sells $1.7 Million in Stock as Shares Significantly Outperform the Market

DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Freeport-McMoran

What Investors Should Know About a $186K OneStream Insider Stock Sale

FRMI INVESTOR NOTICE: Fermi Inc. Investors with Substantial Losses Have Opportunity to Lead the Fermi Class Action Lawsuit

Google teams up with Walmart and other retailers to enable shopping within Gemini AI chatbot

Is the Schwab U.S. Dividend Equity ETF a Buy Now?

SoFi: Illogical Analyst Hate

Stoke Therapeutics Announces Updates to Timelines for the Completion of Enrollment and a Phase 3 Data Readout from the EMPEROR Study of Zorevunersen for the Treatment of Dravet Syndrome

DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Firefly Aerospace

Should You Forget AGNC Investment and Buy Realty Income Instead?

Dutch Bros: Could This Fast-Growing Coffee Chain Be a Long-Term Winner?​

3 AI Stocks Poised for Explosive Growth as Enterprise Spending Accelerates in 2026